Aspectos proteómicos y genéticos de la resistencia a la aspirina
- P.J. Mateos Cáceres
- Luis Azcona
- Antonio Fernández-Ortiz
- D. Sacristán
- Esther Bernardo
- Priscila Ramos Mozo
- Sergio Alonso Orgaz
- Miguel Fernández Arquero
- Antonio López Farré
- Carlos Macaya Miguel
ISSN: 1888-6116
Datum der Publikation: 2008
Ausgabe: 19
Nummer: 3
Seiten: 143-151
Art: Artikel
Andere Publikationen in: Trauma
Zusammenfassung
Aim: To evaluate the existence of a possible association between Aspirin resistance (AR), COX-1 single-nucleotide polymorphisms (SNPs) and the modifications in the plasma proteome of clinically stable coronary patients. Materials and methods: AR was defined according to the PFA-100 assay. AR-sensitive and AR-resistant patients had been taken aspirin for the last 9 months. The proteomic study (19 AR-sensitive, 19 AR-resistant) was performed using IPG strips (17cm, pH 4-7), SDS-PAGE gels (10%) and silver staining. We study three SNPs (A- 842G, C22T y C50T) in 50 AR-sensitive patients, 33 AR-resistant and 83 controls using a real-time PCR. Results: The expression of four ·1-antitripsin isoforms was increased in the aspirin-resistant patients. No differences were found in the expression of ceruloplasmin, haptoglobin-precursor, apolipoprotein-AI and albumin- precursor between both groups of patients. The A-842G SNP was undetectable in all subjects. The remaining two SNPs (C22T y C50T) showed a low frequency with respect the global population. Conclusions: The low SNPs frequencies were unlikely to explain the difference in aspirin responsiveness between both groups of patients. The changes in ·1-antitripsin could be linked with a different inflammatory state in these patients